The recent report that injection of mesenchymal stem cells (MSCs) reverses clinical and peripheral manifestations of COVID-1967 and the fact that GM-CSF is well known to stimulate the mobilization of MSCs from the bone marrow68–70 provide further support for the argument that GM-CSF administration may effectively treat COVID-19. Here, CSF2 is linked to COVID-19.